Neoadjuvant chemotherapy in epithelial ovarian cancer: Largest single institute experience
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
Neoadjuvant chemotherapy in epithelial ovarian cancer: Largest single institute experience ; volume:02 ; number:S 01 ; year:2016 ; 01
Konferenz: 16th Annual International Conference RGCON; 2017-02-03; Habitat World, India habitat Centre, Delhi
Asian Journal of Oncology ; 02, Heft S 01 (2016), 01
- Beteiligte Personen und Organisationen
-
Kumar, Siva
- DOI
-
10.1055/s-0039-1685313
- URN
-
urn:nbn:de:101:1-2019090911084086187717
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:33 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Kumar, Siva
Ähnliche Objekte (12)
Neoadjuvant chemotherapy in epithelial ovarian cancer: Largest single institute experience
Neoadjuvant Chemotherapy in Advanced Epithelial Ovarian Cancer: A Retrospective Study
Neoadjuvant chemotherapy in advanced epithelial ovarian cancer: A survival study
Neoadjuvant Chemotherapy for Advanced Ovarian Cancer
Neoadjuvant Chemotherapy (NACT) in Advanced Epithelial Ovarian Cancer: International Data and TMH Experience
Neo-adjuvant Chemotherapy in Advanced Epithelial Ovarian Cancer (EOC): A Prospective, Randomized Study
Does neoadjuvant chemotherapy reduce surgical complexity in patients with advanced-stage epithelial ovarian cancer?
Evaluating the benefits of neoadjuvant chemotherapy for advanced epithelial ovarian cancer: a retrospective study
Chemotherapy for Advanced Epithelial Ovarian Cancer
Adjuvant vs Neoadjuvant Chemotherapy In Advanced Ovarian Cancer
Neoadjuvant chemotherapy followed by interval debulking surgery for advanced epithelial ovarian cancer: GOTIC-019 study
Uptake and outcomes of neoadjuvant chemotherapy among US patients with less common epithelial ovarian carcinomas
Neoadjuvant chemotherapy in epithelial ovarian cancer: Largest single institute experience
Neoadjuvant Chemotherapy in Advanced Epithelial Ovarian Cancer: A Retrospective Study
Neoadjuvant chemotherapy in advanced epithelial ovarian cancer: A survival study
Neoadjuvant Chemotherapy for Advanced Ovarian Cancer
Neoadjuvant Chemotherapy (NACT) in Advanced Epithelial Ovarian Cancer: International Data and TMH Experience
Neo-adjuvant Chemotherapy in Advanced Epithelial Ovarian Cancer (EOC): A Prospective, Randomized Study
Does neoadjuvant chemotherapy reduce surgical complexity in patients with advanced-stage epithelial ovarian cancer?
Evaluating the benefits of neoadjuvant chemotherapy for advanced epithelial ovarian cancer: a retrospective study
Chemotherapy for Advanced Epithelial Ovarian Cancer
Adjuvant vs Neoadjuvant Chemotherapy In Advanced Ovarian Cancer
Neoadjuvant chemotherapy followed by interval debulking surgery for advanced epithelial ovarian cancer: GOTIC-019 study
Uptake and outcomes of neoadjuvant chemotherapy among US patients with less common epithelial ovarian carcinomas
Neoadjuvant chemotherapy in epithelial ovarian cancer: Largest single institute experience
Neoadjuvant Chemotherapy in Advanced Epithelial Ovarian Cancer: A Retrospective Study
Neoadjuvant chemotherapy in advanced epithelial ovarian cancer: A survival study
Neoadjuvant Chemotherapy for Advanced Ovarian Cancer
Neoadjuvant Chemotherapy (NACT) in Advanced Epithelial Ovarian Cancer: International Data and TMH Experience
Neo-adjuvant Chemotherapy in Advanced Epithelial Ovarian Cancer (EOC): A Prospective, Randomized Study
Does neoadjuvant chemotherapy reduce surgical complexity in patients with advanced-stage epithelial ovarian cancer?
Evaluating the benefits of neoadjuvant chemotherapy for advanced epithelial ovarian cancer: a retrospective study
Chemotherapy for Advanced Epithelial Ovarian Cancer
Adjuvant vs Neoadjuvant Chemotherapy In Advanced Ovarian Cancer
Neoadjuvant chemotherapy followed by interval debulking surgery for advanced epithelial ovarian cancer: GOTIC-019 study